Integrase inhibitors to treat HIV/Aids

[1]  Y. Pommier,et al.  Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery. , 2005, Trends in pharmacological sciences.

[2]  Y. Pommier,et al.  Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin. , 2004, Bioorganic & medicinal chemistry letters.

[3]  J. Mouscadet,et al.  Nuclear Import of HIV-1 Integrase Is Inhibited in Vitro by Styrylquinoline Derivatives , 2004, Molecular Pharmacology.

[4]  G. Hannon,et al.  Crystal Structure of Argonaute and Its Implications for RISC Slicer Activity , 2004, Science.

[5]  Pamela A Silver,et al.  Human cell proteins and human immunodeficiency virus DNA integration. , 2004, Frontiers in bioscience : a journal and virtual library.

[6]  H. Jaffe.  Whatever Happened to the U.S. AIDS Epidemic? , 2004, Science.

[7]  P. Dervan,et al.  Expanding the repertoire of heterocycle ring pairs for programmable minor groove DNA recognition. , 2004, Journal of the American Chemical Society.

[8]  J. Kappes,et al.  Evidence that Stable Retroviral Transduction and Cell Survival following DNA Integration Depend on Components of the Nonhomologous End Joining Repair Pathway , 2004, Journal of Virology.

[9]  Mark Embrey,et al.  A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Pannecouque,et al.  Novel inhibitors of HIV-1 integration. , 2004, Current drug metabolism.

[11]  D. Hazuda,et al.  Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques , 2004, Science.

[12]  C. Vita,et al.  Styrylquinolines, Integrase Inhibitors Acting Prior to Integration: a New Mechanism of Action for Anti-Integrase Agents , 2004, Journal of Virology.

[13]  Y. Pommier,et al.  HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial. , 2004, Current topics in medicinal chemistry.

[14]  S. A. Chow,et al.  Requirement for Integrase during Reverse Transcription of Human Immunodeficiency Virus Type 1 and the Effect of Cysteine Mutations of Integrase on Its Interactions with Reverse Transcriptase , 2004, Journal of Virology.

[15]  D. Davies,et al.  Structure and function of HIV-1 integrase. , 2004, Current topics in medicinal chemistry.

[16]  Y. Pommier,et al.  Azido-Containing Diketo Acid Derivatives Inhibit Human Immunodeficiency Virus Type 1 Integrase In Vivo and Influence the Frequency of Deletions at Two-Long-Terminal-Repeat-Circle Junctions , 2004, Journal of Virology.

[17]  Y. Pommier,et al.  Design and synthesis of photoactivatable aryl diketo acid-containing HIV-1 integrase inhibitors as potential affinity probes. , 2004, Bioorganic & Medicinal Chemistry Letters.

[18]  C. Barbas,et al.  Fusion Proteins Consisting of Human Immunodeficiency Virus Type 1 Integrase and the Designed Polydactyl Zinc Finger Protein E2C Direct Integration of Viral DNA into Specific Sites , 2004, Journal of Virology.

[19]  J. Mouscadet,et al.  The Human Polycomb Group EED Protein Interacts with the Integrase of Human Immunodeficiency Virus Type 1 , 2003, Journal of Virology.

[20]  E. De Clercq,et al.  Development of Resistance against Diketo Derivatives of Human Immunodeficiency Virus Type 1 by Progressive Accumulation of Integrase Mutations , 2003, Journal of Virology.

[21]  Marc C Nicklaus,et al.  Metal-dependent inhibition of HIV-1 integrase by beta-diketo acids and resistance of the soluble double-mutant (F185K/C280S). , 2003, Molecular pharmacology.

[22]  R. Dayam,et al.  Small-molecule HIV-1 integrase inhibitors: the 2001-2002 update. , 2003, Current pharmaceutical design.

[23]  Yaron Werber.  HIV drug market , 2003, Nature reviews. Drug discovery.

[24]  Shawn M. Burgess,et al.  Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.

[25]  Marc C. Nicklaus,et al.  Azido-Containing aryl β-Diketo acid HIV-1 integrase inhibitors , 2003 .

[26]  A. Billich.  S-1360 Shionogi-GlaxoSmithKline. , 2003, Current opinion in investigational drugs.

[27]  D. Hazuda,et al.  Inhibition of HIV-1 Ribonuclease H by a Novel Diketo Acid, 4-[5-(Benzoylamino)thien-2-yl]-2,4-dioxobutanoic Acid* , 2003, The Journal of Biological Chemistry.

[28]  F. Bushman,et al.  Thalassiolins A—C: New Marine-Derived Inhibitors of HIV cDNA Integrase. , 2003 .

[29]  Linghang Zhuang,et al.  Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells. , 2003, Journal of medicinal chemistry.

[30]  Zeger Debyser,et al.  HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells* , 2003, The Journal of Biological Chemistry.

[31]  Dirk Strumberg,et al.  Metal-dependent inhibition of HIV-1 integrase. , 2002, Journal of medicinal chemistry.

[32]  F. Bushman,et al.  Thalassiolins A-C: new marine-derived inhibitors of HIV cDNA integrase. , 2002, Bioorganic & medicinal chemistry.

[33]  Paul Shinn,et al.  HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.

[34]  Myriam Witvrouw,et al.  New Class of HIV Integrase Inhibitors that Block Viral Replication in Cell Culture , 2002, Current Biology.

[35]  Jon Cohen.  Confronting the Limits of Success , 2002, Science.

[36]  Yun Tang,et al.  Structure activity of 3-aryl-1,3-diketo-containing compounds as HIV-1 integrase inhibitors. , 2002, Journal of medicinal chemistry.

[37]  Amy S. Espeseth,et al.  Diketo acid inhibitor mechanism and HIV-1 integrase: Implications for metal binding in the active site of phosphotransferase enzymes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Nouri Neamati,et al.  Patented small molecule inhibitors of HIV-1 integrase: a 10-year saga , 2002 .

[39]  Y. Pommier,et al.  Structural Determinants for HIV-1 Integrase Inhibition by β-Diketo Acids* , 2002, The Journal of Biological Chemistry.

[40]  Y. Pommier,et al.  Effect of HIV integrase inhibitors on the RAG1/2 recombinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Wei Yang,et al.  Structure of a two‐domain fragment of HIV‐1 integrase: implications for domain organization in the intact protein , 2001, The EMBO journal.

[42]  C. Calmels,et al.  Functional Interactions of Human Immunodeficiency Virus Type 1 Integrase with Human and Yeast HSP60 , 2001, Journal of Virology.

[43]  Young Sd.  Inhibition of HIV-1 integrase by small molecules: the potential for a new class of AIDS chemotherapeutics. , 2001 .

[44]  D. Trono,et al.  Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. , 2001, Molecular cell.

[45]  Tania A. Baker,et al.  Comparative architecture of transposase and integrase complexes , 2001, Nature Structural Biology.

[46]  F. Bushman,et al.  Repair of Gaps in Retroviral DNA Integration Intermediates , 2000, Journal of Virology.

[47]  Amy S. Espeseth,et al.  HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Y. Pommier,et al.  Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters. , 2000, Molecular pharmacology.

[49]  R M Stroud,et al.  Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[50]  T. Masuda,et al.  Identification of Critical Amino Acid Residues in Human Immunodeficiency Virus Type 1 IN Required for Efficient Proviral DNA Formation at Steps prior to Integration in Dividing and Nondividing Cells , 2000, Journal of virology.

[51]  M Le Bret,et al.  Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture. , 2000, Journal of medicinal chemistry.

[52]  J A Grobler,et al.  Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. , 2000, Science.

[53]  G. Cohen,et al.  Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Y. Pommier,et al.  Thiazolothiazepine inhibitors of HIV-1 integrase. , 1999, Journal of medicinal chemistry.

[55]  F. Bushman,et al.  Integration complexes derived from HIV vectors for rapid assays in vitro , 1999, Nature Biotechnology.

[56]  Patrick L. Hindmarsh,et al.  HMG Protein Family Members Stimulate Human Immunodeficiency Virus Type 1 and Avian Sarcoma Virus Concerted DNA Integration In Vitro , 1999, Journal of Virology.

[57]  W. Robinson,et al.  Resistance to the Anti-Human Immunodeficiency Virus Type 1 Compound l-Chicoric Acid Results from a Single Mutation at Amino Acid 140 of Integrase , 1998, Journal of Virology.

[58]  F. Bushman,et al.  Human Immunodeficiency Virus Type 1 cDNA Integration: New Aromatic Hydroxylated Inhibitors and Studies of the Inhibition Mechanism , 1998, Antimicrobial Agents and Chemotherapy.

[59]  Y. Pommier,et al.  Highly potent synthetic polyamides, bisdistamycins, and lexitropsins as inhibitors of human immunodeficiency virus type 1 integrase. , 1998, Molecular pharmacology.

[60]  J. Mouscadet,et al.  Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells. , 1998, Journal of medicinal chemistry.

[61]  F. Bushman,et al.  Chromosome Structure and Human Immunodeficiency Virus Type 1 cDNA Integration: Centromeric Alphoid Repeats Are a Disfavored Target , 1998, Journal of Virology.

[62]  A Wlodawer,et al.  Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[63]  E. De Clercq,et al.  Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1. , 1997, Molecular pharmacology.

[64]  D. Hazuda,et al.  Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase , 1997, Journal of virology.

[65]  A Wlodawer,et al.  Binding of Different Divalent Cations to the Active Site of Avian Sarcoma Virus Integrase and Their Effects on Enzymatic Activity* , 1997, The Journal of Biological Chemistry.

[66]  M C Nicklaus,et al.  Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching. , 1997, Journal of medicinal chemistry.

[67]  M C Nicklaus,et al.  Discovery of HIV-1 integrase inhibitors by pharmacophore searching. , 1997, Journal of medicinal chemistry.

[68]  F. Bushman,et al.  HIV-1 cDNA Integration: Requirement of HMG I(Y) Protein for Function of Preintegration Complexes In Vitro , 1997, Cell.

[69]  F. Bushman,et al.  Tethering human immunodeficiency virus type 1 preintegration complexes to target DNA promotes integration at nearby sites , 1997, Journal of virology.

[70]  Y. Pommier,et al.  Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures. , 1996, Biochemistry.

[71]  F. Bushman,et al.  Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[72]  F. Bushman,et al.  Target-sequence preferences of HIV-1 integration complexes in vitro. , 1996, Virology.

[73]  T R Burke,et al.  Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. , 1996, Journal of medicinal chemistry.

[74]  J. Weinstein,et al.  Inhibition of human immunodeficiency virus type-1 integrase by curcumin. , 1995, Biochemical pharmacology.

[75]  T. Steitz,et al.  Recombining the structures of HIV integrase, RuvC and RNase H. , 1995, Structure.

[76]  P. Brown,et al.  Juxtaposition of two viral DNA ends in a bimolecular disintegration reaction mediated by multimers of human immunodeficiency virus type 1 or murine leukemia virus integrase , 1994, Journal of virology.

[77]  K. Kohn,et al.  Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. , 1994, Biochemical pharmacology.

[78]  R. Plasterk,et al.  A high-throughput, non-radioactive microtiter plate assay for activity of the human immunodeficiency virus integrase protein. , 1994, Nucleic acids research.

[79]  D. Hazuda,et al.  A novel assay for the DNA strand-transfer reaction of HIV-1 integrase. , 1994, Nucleic acids research.

[80]  J. Mouscadet,et al.  Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction. , 1993, Archives of biochemistry and biophysics.

[81]  F. Bushman,et al.  Identification of discrete functional domains of HIV‐1 integrase and their organization within an active multimeric complex. , 1993, The EMBO journal.

[82]  K. Kohn,et al.  Inhibitors of human immunodeficiency virus integrase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[83]  A. Engelman,et al.  Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro , 1992, Journal of virology.

[84]  M. Bukrinsky,et al.  Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[85]  Harold E. Varmus,et al.  Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection , 1992, Cell.

[86]  M. Cushman,et al.  Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions. , 1992, Biochemical and biophysical research communications.

[87]  P. Brown,et al.  Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. , 1992, Science.

[88]  F. Bushman,et al.  A rapid in vitro assay for HIV DNA integration. , 1991, Nucleic acids research.

[89]  F. Bushman,et al.  Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[90]  T. Steitz,et al.  Structural basis for the 3′‐5′ exonuclease activity of Escherichia coli DNA polymerase I: a two metal ion mechanism. , 1991, The EMBO journal.

[91]  J. A. Fyfe,et al.  Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[92]  C. Cunningham-Rundles,et al.  Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. , 1981, The New England journal of medicine.

[93]  H. Masur,et al.  An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. , 1981, The New England journal of medicine.

[94]  M. Gottlieb,et al.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. , 1981, The New England journal of medicine.

[95]  Sophie Barbe,et al.  Mechanism of HIV-1 integrase inhibition by styrylquinoline derivatives in vitro. , 2004, Molecular pharmacology.

[96]  Jon Cohen.  Therapies. Confronting the limits of success. , 2002, Science.

[97]  Douglas D. Richman,et al.  HIV chemotherapy , 2001, Nature.

[98]  S. D. Young,et al.  Inhibition of HIV-1 integrase by small molecules: the potential for a new class of AIDS chemotherapeutics. , 2001, Current opinion in drug discovery & development.

[99]  Douglas D. Richman,et al.  HIV chemotherapy : AIDS , 2001 .

[100]  Y. Pommier,et al.  Inhibitors of human immunodeficiency virus integrase. , 1999, Advances in virus research.